Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR'), we wish to inform you that the Board of Directors (the 'Board') of ADS Diagnostic Limited ('the Company') at its meeting held today i.e. Thursday, August 13th, 2026 considered and approved the Unaudited Standalone Financial Results of the Company for the quarter ended 30th June, 2026.\r\nThe Board Meeting commenced at 12:05 p.m. and concluded at 13:10 p.m\r\n